Bcl2L13 is a ceramide synthase inhibitor in glioblastoma

Samuel A. Jensen, Andrea E. Calvert, Giora Volpert, Fotini M. Kouri, Lisa A. Hurley, Janina P. Luciano, Yongfei Wu, Alexandra Chalastanis, Anthony H. Futerman, Alexander H. Stegh

Research output: Contribution to journal › Article › peer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Bcl2L13 is a ceramide synthase inhibitor in glioblastoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology